Does prior MRA use limit eligibility for sacubitril valsartan in a heart failure clinic? Insights from real world experience and implications for ESC and NICE guidelines
27 May 2018 (08:30 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Bristol Heart Institute, Bristol (United Kingdom of Great Britain & Northern Ireland)
61 More presentations in this session
Access the full session
The Event
Heart Failure 2018
27 May 2018
08:30 CET
